Page last updated: 2024-11-05

tribromoacetic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID6415
CHEMBL ID502627
SCHEMBL ID210187
MeSH IDM0068787

Synonyms (38)

Synonym
tribromacetic acid
tribromoacetic acid
75-96-7
einecs 200-919-9
acetic acid, tribromo-
ccris 7887
tribromoacetic acid, 99%
tribromoacetic acid, analytical standard
STL089890
T0351
CHEMBL502627
2,2,2-tribromoacetic acid
NCGC00188893-01
NCGC00188893-02
tox21_200913
cas-75-96-7
dtxsid6021668 ,
NCGC00258467-01
dtxcid301668
AKOS005655320
acetic acid, 2,2,2-tribromo-
71ktl99qjx ,
unii-71ktl99qjx
hsdb 7623
FT-0631319
tribromoacetic acid [hsdb]
tribromoacetic acid [mi]
SCHEMBL210187
W-104381
c2hbr3o2
mfcd00004167
tribromoaceticacid-methylt.
Q20978596
AMY18080
FS-4203
D95394
?tribromoacetic acid
EN300-143018

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Adding chlorine to bromide-rich waters leads to the rapid oxidation of bromide ions and leads to the formation of brominated disinfection by-products (bromo-DBPs) that exert adverse effects on various biological models."( Assessment of individual and mixed toxicity of bromoform, tribromoacetic-acid and 2,4,6 tribromophenol, on the embryo-larval development of Paracentrotus lividus sea urchin.
Austruy, A; Boudenne, JL; Coupé, S; Lebaron, K; Mechiri, L; Richard, S, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency3.24200.001022.650876.6163AID1224893
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency0.48950.000214.376460.0339AID720692
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency6.56540.000627.21521,122.0200AID743202; AID743219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID384213Mutagenic activity in Salmonella Typhimurium TA100 without metabolic activation2008Bioorganic & medicinal chemistry, May-15, Volume: 16, Issue:10
Halogenated derivatives QSAR model using spectral moments to predict haloacetic acids (HAA) mutagenicity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (23.08)18.2507
2000's2 (15.38)29.6817
2010's7 (53.85)24.3611
2020's1 (7.69)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 29.57

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index29.57 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.78 (4.65)
Search Engine Demand Index31.18 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (29.57)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]